Who Owns Edgewise Therapeutics Stock?
NASDAQ: EWTXHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 111.68%
- Institutions (% of float)
- 112.22%
- Held by insiders
- 0.49%
- Institutional holders
- 321
- Institutions 99.5%
- Insiders 0.5%
- Public and other 0.0%
Who owns Edgewise Therapeutics stock?
Institutional investors own about 111.7% of Edgewise Therapeutics's shares, spread across 321 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.49% of EWTX.
The largest institutional holders are Orbimed Advisors LLC. (14.29%), Paradigm Biocapital Advisors LP (9.41%) and RA Capital Management, L.P. (7.73%). Together, the top 10 institutions control 65.0% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their EWTX positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of EWTX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Orbimed Advisors LLC. | 15.52M | 14.29% | 0.0% |
| Paradigm Biocapital Advisors LP | 10.22M | 9.41% | +38.7% |
| RA Capital Management, L.P. | 8.39M | 7.73% | -19.5% |
| Blackrock Inc. | 6.61M | 6.08% | +2.1% |
| Jupiter Topco LLC | 6.08M | 5.59% | +100.0% |
| FMR, LLC | 5.49M | 5.05% | +439.7% |
| Novo Holdings A/S | 5.35M | 4.93% | 0.0% |
| Driehaus Capital Management, LLC | 4.73M | 4.35% | +5.6% |
| Perceptive Advisors Llc | 4.37M | 4.03% | -1.1% |
| Vanguard Capital Management LLC | 3.86M | 3.55% | +1.9% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of EWTX
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.90M | 2.67% |
| iShares Trust-iShares Russell 2000 ETF | 1.82M | 1.68% |
| Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total | 1.54M | 1.42% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 864.64K | 0.80% |
| American Century Mutual Funds, Inc.-Small Cap Growth Fund | 856.21K | 0.79% |
| Victory Portfolios IV-Victory Pioneer Select Mid Cap Growth Fund | 795.79K | 0.73% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 782.05K | 0.72% |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 699.42K | 0.64% |
| JANUS INVESTMENT FUND-Janus Henderson Global Life Sciences Fund | 677.08K | 0.62% |
| iShares Trust-iShares Russell 2000 Growth ETF | 669.16K | 0.62% |
Frequently asked questions
Who is the largest shareholder of Edgewise Therapeutics?
Orbimed Advisors LLC. is the largest institutional shareholder of EWTX, owning 14.29% of shares outstanding (15.52M shares) as of its latest 13F filing.
What percentage of Edgewise Therapeutics is owned by institutions?
Institutions own about 111.7% of EWTX shares and 112.2% of the public float.
How much of Edgewise Therapeutics do insiders own?
Insiders, such as officers and directors, own about 0.49% of EWTX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.